Click it and Unblock the Notifications
Just In
Don't Miss
-
WATCH: Reporter Schools A Man Trying To Moral Policing Her, Internet Hails Her For Leaving ‘No Crumbs’ -
'It Would be Awesome': Rohit Sharma advocates for India vs Pakistan Bilateral Series with Special Condition -
Vivo V30e Launch Date in India set for May 2: Flipkart Availability Confirmed -
Rs 14/Share Dividend: Stockbroking Co To Consider Bonus Share, Shares Up 126% In 180-Days -
Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic -
Journey From Delhi To Ooty: Top Transport Options And Attractions -
IIIT-Bangalore Introduces PG Diploma In Digital Product Design And Management -
Jawa Yezdi Expands Mega Service Camps To 32 New Cities, Focusing On Tier-II And Tier-III Regions
Ivermectin drug: Regular use of oral anti-parasitic drug may cut risk of contracting Covid-19, says Study
New Delhi, May 11: Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting Covid-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.
Recommended Video
The research, published in the May-June issue of the American Journal of Therapeutics, is the most comprehensive review of the available data on ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said.
"We conducted the most comprehensive review of the available data on ivermectin," said Pierre Kory, president and chief medical officer of the Front Line Covid-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts, which led the study.
"We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic," Kory said in a statement.
Ivermectin is an oral drug is used as a prescription medication to treat parasitic infections.
A focus of the study was on the 27 controlled trials available in January 2021, 15 of which were randomised controlled trials (RCT's).
